{"transactions":[{"id":1749433,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-11-03T16:49:45.000Z","date":"2023-11-01","kind":"grant","planned":false,"acquired":true,"shares":437244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on November 1, 2023. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":437244,"derivative":{"exercise_price":0.2088,"expiration_date":"2033-11-01","underlying":"Common Stock","underlying_shares":437244},"source":{"system":"sec-edgar","filing":"0001493152-23-039337","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000149315223039337/ownership.xml","form_type":"4"}},{"id":2114208,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-11-16T21:31:59.000Z","date":"2022-11-14","kind":"grant","acquired":true,"shares":142657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on November 14, 2022. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":142657,"derivative":{"exercise_price":0.7268,"expiration_date":"2032-11-14","underlying":"Common Stock","underlying_shares":142657},"source":{"system":"sec-edgar","filing":"0001493152-22-032688","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000149315222032688/ownership.xml","form_type":"4"}},{"id":2528327,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-02T16:18:31.000Z","date":"2021-11-01","kind":"grant","acquired":true,"shares":90882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2021. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":90882,"derivative":{"exercise_price":1.12,"expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":90882},"source":{"system":"sec-edgar","filing":"0001493152-21-026990","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000149315221026990/ownership.xml","form_type":"4"}},{"id":2655612,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-06-24T17:46:11.000Z","date":"2021-06-19","kind":"exercise","acquired":false,"shares":12,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 19, 2021, pursuant to the Certificate of Designations of Preferences, Rights and Limitations of the Series B Preferred Stock (the \"Certificate\") of the Issuer, all shares of Series B Convertible Preferred Stock were mandatorily converted into shares of the Issuer's common stock. Each share of Series B Convertible Preferred Stock converted into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock were convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate. The Series B Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 19, 2021, pursuant to the Certificate of Designations of Preferences, Rights and Limitations of the Series B Preferred Stock (the \"Certificate\") of the Issuer, all shares of Series B Convertible Preferred Stock were mandatorily converted into shares of the Issuer's common stock. Each share of Series B Convertible Preferred Stock converted into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock were convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate. The Series B Convertible Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0.5,"exercise_date":"2018-06-21","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0000905718-21-000828","document":"matinasbio_fm4jun192021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000090571821000828/matinasbio_fm4jun192021.xml","form_type":"4"}},{"id":2655611,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-06-24T17:46:11.000Z","date":"2021-06-19","kind":"exercise","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 19, 2021, pursuant to the Certificate of Designations of Preferences, Rights and Limitations of the Series B Preferred Stock (the \"Certificate\") of the Issuer, all shares of Series B Convertible Preferred Stock were mandatorily converted into shares of the Issuer's common stock. Each share of Series B Convertible Preferred Stock converted into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock were convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate. The Series B Convertible Preferred Stock had no expiration date."}],"balance_after":649958,"source":{"system":"sec-edgar","filing":"0000905718-21-000828","document":"matinasbio_fm4jun192021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000090571821000828/matinasbio_fm4jun192021.xml","form_type":"4"}},{"id":2655610,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-06-24T17:46:11.000Z","date":"2021-06-19","kind":"other","acquired":true,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Stock dividend, payable to all holders of record of Series B Preferred Stock of 400 shares of Common Stock for each share of Series B Preferred Stock."}],"balance_after":625958,"source":{"system":"sec-edgar","filing":"0000905718-21-000828","document":"matinasbio_fm4jun192021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000090571821000828/matinasbio_fm4jun192021.xml","form_type":"4"}},{"id":2663129,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2021-06-17T18:51:00.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 15, 2022, subject to Mr. Scibetta's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":4.04,"exercise_date":"2022-06-15","expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001214659-21-006715","document":"marketforms-53151.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000121465921006715/marketforms-53151.xml","form_type":"4"}},{"id":2986096,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-11-10T16:05:42.000Z","date":"2020-11-02","kind":"grant","acquired":true,"shares":122605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2020. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":122605,"derivative":{"exercise_price":0.82,"expiration_date":"2030-11-02","underlying":"Common Stock","underlying_shares":122605},"source":{"system":"sec-edgar","filing":"0001493152-20-020924","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000149315220020924/ownership.xml","form_type":"4"}},{"id":3100647,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-06-24T21:00:14.000Z","date":"2020-06-23","kind":"other","acquired":true,"shares":3600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Stock dividend, payable to all holders of record of Series B Preferred Stock of 300 shares of Common Stock for each share of Series B Preferred Stock."}],"balance_after":621158,"source":{"system":"sec-edgar","filing":"0001493152-20-011759","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000149315220011759/ownership.xml","form_type":"4"}},{"id":3105146,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-06-18T16:05:29.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 16, 2021, subject to Mr. Scibetta's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":14000,"derivative":{"exercise_price":5.3,"exercise_date":"2021-06-16","expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001214659-20-005759","document":"marketforms-49055.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000121465920005759/marketforms-49055.xml","form_type":"4"}},{"id":3321845,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-01-03T16:06:05.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":8260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 31, 2019, the Reporting Person was issued 8,260 shares of common stock par value $.0001 per share pursuant to the Issuer's Amended and Restated 2013 Equity Incentive Plan. Such shares vest immediately upon grant."}],"balance_after":617558,"source":{"system":"sec-edgar","filing":"0001493152-20-000126","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000149315220000126/ownership.xml","form_type":"4"}},{"id":3379897,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-11-05T16:05:13.000Z","date":"2019-11-01","kind":"grant","acquired":true,"shares":107416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2019. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":107416,"derivative":{"exercise_price":0.912,"expiration_date":"2029-11-01","underlying":"Common Stock","underlying_shares":107416},"source":{"system":"sec-edgar","filing":"0001493152-19-016455","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000149315219016455/ownership.xml","form_type":"4"}},{"id":3400451,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-10-02T18:06:31.000Z","date":"2019-06-21","kind":"other","acquired":true,"shares":2400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock dividend, payable to all holders of records of Series B Preferred Stock of 200 shares of Common Stock for each share of Series B Preferred Stock."}],"balance_after":609298,"source":{"system":"sec-edgar","filing":"0001493152-19-014910","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000149315219014910/ownership.xml","form_type":"4"}},{"id":3400450,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-10-02T18:06:31.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":29739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 30, 2019, the Reporting Person was issued 29,739 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":606898,"source":{"system":"sec-edgar","filing":"0001493152-19-014910","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000149315219014910/ownership.xml","form_type":"4"}},{"id":3430835,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-22T16:30:15.000Z","date":"2019-08-21","kind":"purchase","acquired":true,"shares":900,"price":3.81,"value":3429.0,"ownership":{"direct":true},"balance_after":31635,"source":{"system":"sec-edgar","filing":"0001214659-19-005414","document":"marketforms-45533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000121465919005414/marketforms-45533.xml","form_type":"4"}},{"id":3430834,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-22T16:30:15.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":11310,"price":3.802,"value":43000.62,"ownership":{"direct":true},"balance_after":30735,"source":{"system":"sec-edgar","filing":"0001214659-19-005414","document":"marketforms-45533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000121465919005414/marketforms-45533.xml","form_type":"4"}},{"id":3430833,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-22T16:30:15.000Z","date":"2019-08-19","kind":"purchase","acquired":true,"shares":10761,"price":3.768,"value":40547.448,"ownership":{"direct":true},"balance_after":19425,"source":{"system":"sec-edgar","filing":"0001214659-19-005414","document":"marketforms-45533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000121465919005414/marketforms-45533.xml","form_type":"4"}},{"id":3470481,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-02T18:42:03.000Z","date":"2019-06-30","kind":"grant","acquired":true,"shares":21879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 30, 2019, the Reporting Person was issued 21,879 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":577159,"source":{"system":"sec-edgar","filing":"0001493152-19-010200","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000149315219010200/ownership.xml","form_type":"4"}},{"id":3487399,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2019-06-17T16:47:09.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":13350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 13, 2020, subject to Mr. Scibetta's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":13350,"derivative":{"exercise_price":4.38,"exercise_date":"2020-06-13","expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":13350},"source":{"system":"sec-edgar","filing":"0001214659-19-004244","document":"marketforms-45224.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000121465919004244/marketforms-45224.xml","form_type":"4"}},{"id":3563937,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-03T16:40:19.000Z","date":"2019-03-31","kind":"grant","acquired":true,"shares":17202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 31, 2019, the Reporting Person was issued 17,202 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":555280,"source":{"system":"sec-edgar","filing":"0000905718-19-000325","document":"matinas_fm4mar312019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000090571819000325/matinas_fm4mar312019.xml","form_type":"4"}},{"id":3703251,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-04T16:01:31.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":31513,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 31, 2018, the Reporting Person was issued 31,513 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":538078,"source":{"system":"sec-edgar","filing":"0000905718-19-000019","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000090571819000019/ownership.xml","form_type":"4"}},{"id":3773867,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-11-05T08:18:19.000Z","date":"2018-11-01","kind":"grant","acquired":true,"shares":128299,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":128299,"derivative":{"exercise_price":0.74,"exercise_date":"2018-11-01","expiration_date":"2028-10-31","underlying":"Common Stock","underlying_shares":128299},"source":{"system":"sec-edgar","filing":"0000905718-18-000910","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000090571818000910/ownership.xml","form_type":"4"}},{"id":3773866,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-11-05T08:18:19.000Z","date":"2018-11-01","kind":"grant","acquired":true,"shares":128299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2018. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":128299,"derivative":{"exercise_price":0.74,"expiration_date":"2028-10-31","underlying":"Common Stock","underlying_shares":128299},"source":{"system":"sec-edgar","filing":"0000905718-18-000910","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000090571818000910/ownership.xml","form_type":"4"}},{"id":3798048,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-03T16:27:33.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":20381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On Octopber 1, 2018, the Reporting Person was granted 20,381 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On Octopber 1, 2018, the Reporting Person was granted 20,381 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":506565,"source":{"system":"sec-edgar","filing":"0000905718-18-000819","document":"scibetta_form4jun292018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000090571818000819/scibetta_form4jun292018.xml","form_type":"4"}},{"id":3860699,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true}}],"security":"Stock Option (Right to Purchase)","published_at":"2018-07-26T21:10:12.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":26700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 25% of the underlying shares vest on the first anniversary of the grant date, 25% of the underlying shares vest on the second anniversary of the grant date and the remaining 50% of the underlying shares vest on the third anniversary of the grant date, subject in each case to Mr. Scibetta's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":26700,"derivative":{"exercise_price":15,"expiration_date":"2028-07-24","underlying":"Common Stock","underlying_shares":26700},"source":{"system":"sec-edgar","filing":"0001140361-18-033741","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000114036118033741/form4.xml","form_type":"4"}},{"id":3869134,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-11T16:38:06.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":43203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 29, 2018, the Reporting Person was granted 43,203 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan.  Such shares vest immediately upon grant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 29, 2018, the Reporting Person was granted 43,203 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan.  Such shares vest immediately upon grant."}],"balance_after":486184,"source":{"system":"sec-edgar","filing":"0000905718-18-000624","document":"scibetta_form4jun292018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000090571818000624/scibetta_form4jun292018.xml","form_type":"4"}},{"id":3884735,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-06-22T16:43:51.000Z","date":"2018-06-21","kind":"purchase","acquired":true,"shares":12,"price":1000,"value":12000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 21, 2018, the Reporting Person purchased 12 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On June 21, 2018, the Reporting Person purchased 12 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date."}],"balance_after":12,"derivative":{"exercise_price":0.5,"exercise_date":"2018-06-21","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0000905718-18-000592","document":"scibetta_form4jun212018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000090571818000592/scibetta_form4jun212018.xml","form_type":"4"}},{"id":3976055,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-02T17:12:45.000Z","date":"2018-03-30","kind":"grant","acquired":true,"shares":24672,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 30, 2018, the Reporting Person was issued 24,672 shares of common stock par value $.0001 per share which vest immediately upon grant."}],"balance_after":442981,"source":{"system":"sec-edgar","filing":"0000905718-18-000361","document":"scibetta_form4mar302018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000090571818000361/scibetta_form4mar302018.xml","form_type":"4"}},{"id":4214535,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T17:04:22.000Z","date":"2017-09-07","kind":"purchase","acquired":true,"shares":5000,"price":1.29,"value":6450.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.23 to $1.37, inclusive. The reporting person undertakes to provide Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":418309,"source":{"system":"sec-edgar","filing":"0000905718-17-000823","document":"scibetta_form4sep72017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000090571817000823/scibetta_form4sep72017.xml","form_type":"4"}},{"id":4289556,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2017-06-07T19:00:29.000Z","date":"2017-06-05","kind":"sale","acquired":false,"shares":1966,"price":43.321,"value":85169.086,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":25118,"source":{"system":"sec-edgar","filing":"0001209191-17-038420","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000120919117038420/doc4.xml","form_type":"4"}},{"id":4315217,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-17T18:44:37.000Z","date":"2017-05-15","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 25% of the option shares on December 29, 2011 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. The option shares become exercisable, to the extent vested, from and after the Issuer's initial public offering."}],"balance_after":15251,"derivative":{"exercise_price":5.49,"expiration_date":"2020-12-29","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-17-033404","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000120919117033404/doc4.xml","form_type":"4"}},{"id":4315216,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2017-05-17T18:44:37.000Z","date":"2017-05-15","kind":"sale","acquired":false,"shares":20000,"price":51.2,"value":1024000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.00 to $51.60, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":27084,"source":{"system":"sec-edgar","filing":"0001209191-17-033404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000120919117033404/doc4.xml","form_type":"4"}},{"id":4315215,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2017-05-17T18:44:37.000Z","date":"2017-05-15","kind":"exercise","acquired":true,"shares":20000,"price":5.49,"value":109800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":47084,"source":{"system":"sec-edgar","filing":"0001209191-17-033404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000120919117033404/doc4.xml","form_type":"4"}},{"id":4486201,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-19T18:50:50.000Z","date":"2017-01-17","kind":"exercise","acquired":false,"shares":17627,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests as to 25% of the option shares on December 29, 2011 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. The option shares become exercisable, to the extent vested, from and after the Issuer's initial public offering."}],"balance_after":35251,"derivative":{"exercise_price":5.49,"expiration_date":"2020-12-29","underlying":"Common Stock","underlying_shares":17627},"source":{"system":"sec-edgar","filing":"0001209191-17-004637","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000120919117004637/doc4.xml","form_type":"4"}},{"id":4486200,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-19T18:50:50.000Z","date":"2017-01-17","kind":"exercise","acquired":false,"shares":2373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested as to 50% of the options on September 2, 2010 and vests as to the remaining options in successive equal monthly installments for the subsequent 24 months. The options become exercisable, to the extent vested, from and after the issuer's initial public offering."}],"balance_after":0,"derivative":{"exercise_price":1.61,"expiration_date":"2020-09-02","underlying":"Common Stock","underlying_shares":2373},"source":{"system":"sec-edgar","filing":"0001209191-17-004637","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000120919117004637/doc4.xml","form_type":"4"}},{"id":4486199,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2017-01-19T18:50:50.000Z","date":"2017-01-17","kind":"sale","acquired":false,"shares":4997,"price":38.97,"value":194733.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.80 to $39.05, inclusive."}],"balance_after":27084,"source":{"system":"sec-edgar","filing":"0001209191-17-004637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000120919117004637/doc4.xml","form_type":"4"}},{"id":4486198,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2017-01-19T18:50:50.000Z","date":"2017-01-17","kind":"sale","acquired":false,"shares":15003,"price":38.39,"value":575965.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.80 to $38.75, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3."}],"balance_after":32081,"source":{"system":"sec-edgar","filing":"0001209191-17-004637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000120919117004637/doc4.xml","form_type":"4"}},{"id":4486197,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2017-01-19T18:50:50.000Z","date":"2017-01-17","kind":"exercise","acquired":true,"shares":17627,"price":5.49,"value":96772.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":47084,"source":{"system":"sec-edgar","filing":"0001209191-17-004637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000120919117004637/doc4.xml","form_type":"4"}},{"id":4486196,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2017-01-19T18:50:50.000Z","date":"2017-01-17","kind":"exercise","acquired":true,"shares":2373,"price":1.61,"value":3820.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":29457,"source":{"system":"sec-edgar","filing":"0001209191-17-004637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000120919117004637/doc4.xml","form_type":"4"}},{"id":4526830,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-09T20:25:30.000Z","date":"2016-12-07","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":20000,"derivative":{"exercise_price":32.35,"expiration_date":"2026-12-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-16-154558","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000120919116154558/doc4.xml","form_type":"4"}},{"id":4549991,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-17T17:41:00.000Z","date":"2016-11-15","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested as to 50% of the options on September 2, 2010 and vests as to the remaining options in successive equal monthly installments for the subsequent 24 months. The options become exercisable, to the extent vested, from and after the issuer's initial public offering."}],"balance_after":2373,"derivative":{"exercise_price":1.61,"expiration_date":"2020-09-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-16-150960","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000120919116150960/doc4.xml","form_type":"4"}},{"id":4549990,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2016-11-17T17:41:00.000Z","date":"2016-11-15","kind":"sale","acquired":false,"shares":20000,"price":36.5,"value":730000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":27084,"source":{"system":"sec-edgar","filing":"0001209191-16-150960","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000120919116150960/doc4.xml","form_type":"4"}},{"id":4549989,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":108594,"kind":"person","name":"Scibetta James S","position":1,"cik":"0001383242","reported_name":"Scibetta James S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2016-11-17T17:41:00.000Z","date":"2016-11-15","kind":"exercise","acquired":true,"shares":20000,"price":1.61,"value":32200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":47084,"source":{"system":"sec-edgar","filing":"0001209191-16-150960","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383242/000120919116150960/doc4.xml","form_type":"4"}}]}